Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Mar-23 4:59 PM View:  | Bausch & Lomb Corp (BLCO) | 01-Mar-23 | Grant | 21,258 | -- | -- | 20% 104.44K to 125.7K | |
| 27-Jul-22 7:41 PM View: | Bausch & Lomb Corp (BLCO) | 25-Jul-22 | Grant | 35,000 | -- | -- | 50% 69.44K to 104.44K | |
| 09-May-22 6:46 PM View: | Bausch & Lomb Corp (BLCO) | 05-May-22 | Grant | 69,444 | -- | -- | 100% 0 to 69.44K | |
| 10-Mar-22 4:03 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-22 | Market Sale (Planned) | 3,889 | $21.76 | $84,624.60 | (4%) 97.03K to 93.14K | (< 1%) |
| 07-Mar-22 5:32 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-22 | Payment of Exercise | 4,074 | $23.61 | $96,187.10 | (4%) 101.1K to 97.03K | |
| 04-Mar-22 4:58 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-22 | Private Sale (Planned) | 11,077 | $23.37 | $258,870.00 | (10%) 112.18K to 101.1K | |
| 02-Mar-22 9:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-22 | Planned Option Sale | 6,338 | $23.82 | $150,971.00 | (5%) 118.52K to 112.18K | |
| 02-Mar-22 9:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Payment of Exercise | 7,949 | $24.35 | $193,558.00 | (6%) 126.47K to 118.52K | |
| 02-Mar-22 9:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Option Exercise | 17,350 | -- | -- | 16% 109.12K to 126.47K | |
| 02-Mar-22 9:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-22 | Payment of Exercise | 1,522 | $24.35 | $37,060.70 | (1%) 121.75K to 120.23K | |
| 10-Mar-21 8:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-21 | Payment of Exercise | 12,461 | $32.97 | $410,839.00 | (10%) 123.1K to 110.64K | |
| 10-Mar-21 8:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Grant | 17,320 | -- | -- | 17% 100.14K to 117.46K | |
| 10-Mar-21 8:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Option Exercise | 5,637 | -- | -- | 5% 117.46K to 123.1K | |
| 05-Mar-21 5:57 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-21 | Grant | 23,892 | -- | -- | 31% 76.25K to 100.14K | |
| 03-Mar-21 4:43 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-21 | Payment of Exercise | 3,313 | $31.42 | $104,094.00 | (4%) 79.56K to 76.25K | |
| 11-Mar-20 8:59 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Mar-20 | Payment of Exercise | 2,239 | $20.96 | $46,929.40 | (3%) 81.8K to 79.56K | (4%) |
| 03-Mar-20 5:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-20 | Payment of Exercise | 2,499 | $24.44 | $61,075.60 | (3%) 84.3K to 81.8K | |
| 28-Feb-20 7:30 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-20 | Grant | 13,506 | -- | -- | 19% 70.8K to 84.3K | |
| 21-Feb-20 9:58 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Feb-20 | Payment of Exercise | 11,703 | $26.46 | $309,661.00 | (14%) 82.5K to 70.8K | |
| 21-Feb-20 9:58 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Grant | 28,178 | -- | -- | 57% 49.08K to 77.26K | |
| 21-Feb-20 9:58 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Option Exercise | 5,242 | -- | -- | 7% 77.26K to 82.5K | |
| 09-Jan-20 4:24 PM View: | Valeant Pharmaceuticals Int... (BHC) | 07-Jan-20 | Payment of Exercise | 2,118 | $29.42 | $62,311.60 | (4%) 51.2K to 49.08K | |
| 08-May-19 4:25 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-May-19 | Payment of Exercise | 693 | $23.51 | $16,292.40 | (1%) 51.89K to 51.2K | (8%) |
| 12-Mar-19 4:28 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-19 | Payment of Exercise | 1,557 | $23.56 | $36,682.90 | (3%) 53.45K to 51.89K | < 1% |
| 01-Mar-19 5:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-19 | Grant | 15,221 | -- | -- | 40% 38.23K to 53.45K | |
| 10-Jan-19 4:10 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Jan-19 | Payment of Exercise | 2,169 | $21.25 | $46,091.20 | (5%) 40.39K to 38.23K | (12%) |